13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002054496
Total reported value
$113.2M
$113.2M
24 檔
277.8%
According to the latest 13F quarterly dataset, Eleva Capital SAS managed an equity portfolio of $113.2M at the end of Q2 2026, spanning 24 distinct U.S. exchange-listed positions.
During Q2 2026, Eleva Capital SAS's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CRH, AS, NVDA) accounted for 277.8% of total reported equity market value during Q2 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRH | CRH plc | Stock-Materials | 81.27% | -81.27% | EXIT | |
| 2 | AS | Amer Sports, Inc. | Stock-Consumer Disc | 2.86% | -2.86% | EXIT | |
| 3 | NVDA | Nvidia CORP | Stock-Tech | 2.64% | -1.19% | — | |
| 4 | NFLX | Netflix Inc | Stock-Comm Services | 2.44% | -2.44% | EXIT | |
| 5 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 2.34% | +4.08% | — | |
| 6 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 1.89% | +9.43% | — | |
| 7 | ANET | Arista Networks Inc | Stock-Tech | 1.68% | +3.41% | — | |
| 8 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.98% | +13.02% | — | |
| 9 | TMUS | T-mobile US Inc | Stock-Comm Services | 0.88% | -0.88% | EXIT | |
| 10 | HOOD | Robinhood Markets Inc - A | Stock-Financials | 0.64% | +4.87% | — | |
| 11 | ✓ | On Holding AG | Stock-Other | 0.50% | -0.50% | EXIT | |
| 12 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.49% | -0.49% | EXIT | |
| 13 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 0.38% | -0.38% | EXIT | |
| 14 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.24% | -0.24% | EXIT | |
| 15 | CGON | Cg Oncology Inc | Stock-Other | 0.16% | -0.16% | EXIT | |
| 16 | ESPR | Esperion Therapeutics Inc | Stock-Other | 0.15% | -0.15% | EXIT | |
| 17 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.13% | -0.13% | EXIT | |
| 18 | FENC | Fennec Pharmaceuticals Inc | Stock-Other | 0.10% | -0.10% | EXIT | |
| 19 | IRON | Disc Medicine Inc | Stock-Other | 0.10% | -0.10% | EXIT | |
| 20 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.04% | -0.04% | EXIT | |
| 21 | FCX | Freeport-mcmoran Inc | Stock-Materials | 0.04% | +0.89% | — | |
| 22 | ACHR | Archer Aviation Inc-a | Stock-Industrials | 0.03% | -0.03% | EXIT | |
| 23 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 0.02% | -0.02% | EXIT | |
| 24 | AQST | Aquestive Therapeutics Inc | Stock-Other | — | — | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TSM | Taiwan Semiconductor-sp Adr | — | — | Unchanged |
| 2 | ESPR | Esperion Therapeutics Inc | — | — | Unchanged |
| 3 | AS | Amer Sports, Inc. | — | — | Unchanged |
| 4 | CRH | CRH plc | — | — | Unchanged |
| 5 | TMUS | T-mobile US Inc | — | — | Unchanged |
| 6 | VRDN | Viridian Therapeutics Inc | — | — | Unchanged |
| 7 | IRON | Disc Medicine Inc | — | — | Unchanged |
| 8 | ACHR | Archer Aviation Inc-a | — | — | Unchanged |
| 9 | HOOD | Robinhood Markets Inc - A | — | — | Unchanged |
| 10 | AQST | Aquestive Therapeutics Inc | — | — | Unchanged |
| 11 | ✓ | On Holding AG | — | — | Unchanged |
| 12 | NVDA | Nvidia CORP | — | — | Unchanged |
| 13 | ANET | Arista Networks Inc | — | — | Unchanged |
| 14 | GOOGL | Alphabet Inc-cl A | — | — | Unchanged |
| 15 | BSX | Boston Scientific CORP | — | — | Unchanged |
| 16 | NFLX | Netflix Inc | — | — | Unchanged |
| 17 | FCX | Freeport-mcmoran Inc | — | — | Unchanged |
| 18 | FENC | Fennec Pharmaceuticals Inc | — | — | Unchanged |
| 19 | EWTX | Edgewise Therapeutics Inc | — | — | Unchanged |
| 20 | SPOT | Spotify Technology S.A. | — | — | Unchanged |
| 21 | MLYS | Mineralys Therapeutics Inc | — | — | Unchanged |
| 22 | NAMS | NewAmsterdam Pharma Company N.V. | — | — | Unchanged |
| 23 | AMZN | Amazon.com Inc | — | — | Unchanged |
| 24 | CGON | Cg Oncology Inc | — | — | Unchanged |
According to official SEC Form 13F filings, Eleva Capital SAS reported a total U.S. public equity portfolio value of $113.2M across 24 disclosed positions in Q2 2026.
During Q2 2026, Eleva Capital SAS's top holdings by market value included CRH (81.3%)、AS (2.9%)、NVDA (2.6%). The largest single position, CRH, represented 81.3% of total portfolio value.
In Q2 2026, Eleva Capital SAS made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.